FUNCTIONAL INTERACTIONS OF GALANIN AND ACETYLCHOLINE - RELEVANCE TO MEMORY AND ALZHEIMERS-DISEASE

被引:54
作者
CRAWLEY, JN
机构
[1] Section on Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, MD 20892, Building 10
关键词
ALZHEIMERS DISEASE; MEMORY; LEARNING; HIPPOCAMPUS; NEUROPEPTIDE; COEXISTENCE; CHOLINERGIC; GALANIN;
D O I
10.1016/0166-4328(93)90129-E
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Galanin, a 29-amino acid neuropeptide, is the only peptide known to coexist with acetylcholine in the basal forebrain neurons which degenerate early in the progression of Alzheimer's disease. Biochemical and neurophysiological studies demonstrated inhibitory actions of galanin on cholinergic functions. Behavioral investigations found that intracerebrally administered galanin produces deficits on spatial learning and memory tasks in rats. Taken together, the current literature suggests that galanin acts as an inhibitory modulator of acetylcholine in this coexistence. Particularly in the case of Alzheimer's disease, where cholinergic activity is severely compromised, the negative actions of galanin may be particularly deleterious. Recently developed galanin antagonists may provide a novel therapeutic approach toward enhancing memory processes in Alzheimer's disease, by removing the putative inhibitory actions of endogenous galanin on the remaining basal forebrain cholinergic neurons.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 81 条
[1]   TYROSINE-HYDROXYLASE AND GALANIN MESSENGER-RNA LEVELS IN LOCUS-CERULEUS NEURONS ARE INCREASED FOLLOWING RESERPINE ADMINISTRATION [J].
AUSTIN, MC ;
COTTINGHAM, SL ;
PAUL, SM ;
CRAWLEY, JN .
SYNAPSE, 1990, 6 (04) :351-357
[2]   GALANIN AND GALANIN ANTAGONISTS - MOLECULAR AND BIOCHEMICAL PERSPECTIVES [J].
BARTFAI, T ;
FISONE, G ;
LANGEL, U .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (08) :312-317
[3]   M-15 - HIGH-AFFINITY CHIMERIC PEPTIDE THAT BLOCKS THE NEURONAL ACTIONS OF GALANIN IN THE HIPPOCAMPUS, LOCUS-CERULEUS, AND SPINAL-CORD [J].
BARTFAI, T ;
BEDECS, K ;
LAND, T ;
LANGEL, U ;
BERTORELLI, R ;
GIROTTI, P ;
CONSOLO, S ;
XU, XJ ;
WIESENFELDHALLIN, Z ;
NILSSON, S ;
PIERIBONE, VA ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10961-10965
[4]   GALANIN IMMUNOREACTIVITY IS INCREASED IN THE NUCLEUS BASALIS OF MEYNERT IN ALZHEIMERS-DISEASE [J].
BEAL, MF ;
MACGARVEY, U ;
SWARTZ, KJ .
ANNALS OF NEUROLOGY, 1990, 28 (02) :157-161
[5]   GALANIN-LIKE IMMUNOREACTIVITY IS UNCHANGED IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE DEMENTIA CEREBRAL-CORTEX [J].
BEAL, MF ;
CLEVENS, RA ;
CHATTHA, GK ;
MACGARVEY, UM ;
MAZUREK, MF ;
GABRIEL, SM .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) :1935-1941
[6]   GALANIN PROTECTS HIPPOCAMPAL-NEURONS FROM THE FUNCTIONAL-EFFECTS OF ANOXIA [J].
BENARI, Y ;
LAZDUNSKI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (2-3) :331-332
[7]   GALANIN IMMUNOREACTIVITY IN HUMAN CSF - STUDIES IN EATING DISORDERS AND ALZHEIMERS-DISEASE [J].
BERRETTINI, WH ;
KAYE, WH ;
SUNDERLAND, T ;
MAY, C ;
GWIRTSMAN, HE ;
MELLOW, A ;
ALBRIGHT, A .
NEUROPSYCHOBIOLOGY, 1988, 19 (02) :64-68
[10]   PERTUSSIS TOXIN-SENSITIVE G-PROTEIN MEDIATES GALANINS INHIBITION OF SCOPOLAMINE-EVOKED ACETYLCHOLINE-RELEASE INVIVO AND CARBACHOL-STIMULATED PHOSPHOINOSITIDE TURNOVER IN RAT VENTRAL HIPPOCAMPUS [J].
CONSOLO, S ;
BERTORELLI, R ;
GIROTTI, P ;
LAPORTA, C ;
BARTFAI, T ;
PARENTI, M ;
ZAMBELLI, M .
NEUROSCIENCE LETTERS, 1991, 126 (01) :29-32